Charuvastra & William Shell Family Trust Elizabeth, 10% Owner (NONE), bought 869,103 shares at $4.26 ($1.1M) on 2013-04-22, disclosed to the SEC on 2013-07-23.
Open-market purchase of $1.1M NONE by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.10 | 10,000 | $21K | 1.9% |
| 2 | $2.11 | 4,000 | $8K | 0.8% |
| 3 | $2.14 | 7,500 | $16K | 1.5% |
| 4 | $2.15 | 1,000 | $2K | 0.2% |
| 5 | $2.31 | 11,000 | $25K | 2.3% |
| 6 | $2.32 | 21,500 |
| Ticker | Type | Filed | Value | 7d Stock | Filing |
|---|---|---|---|---|---|
| TRGM | BUY | 2013-09-04 | $32K | — | Filing → |
| PrivateTargeted Medical Pharma, Inc. | BUY |
| $50K |
| 4.5% |
| 7 | $2.91 | 12,149 | $35K | 3.2% |
| 8 | $3.82 | 21,600 | $83K | 7.5% |
| 9 | $3.85 | 4,500 | $17K | 1.6% |
| 10 | $3.94 | 14,000 | $55K | 5.0% |
| 11 | $4.00 | 1,000 | $4K | 0.4% |
| 12 | $4.08 | 16,200 | $66K | 6.0% |
| 13 | $4.38 | 1,000 | $4K | 0.4% |
| 14 | $4.51 | 39,200 | $177K | 16.0% |
| 15 | $4.97 | 659 | $3K | 0.3% |
| 16 | $4.47 | 6,000 | $27K | 2.4% |
| 17 | $4.49 | 32,000 | $144K | 13.0% |
| 18 | $4.59 | 30,500 | $140K | 12.7% |
| 19 | $4.65 | 6,000 | $28K | 2.5% |
| 20 | $4.91 | 13,500 | $66K | 6.0% |
| 21 | $4.35 | 1,000 | $4K | 0.4% |
| 22 | $4.73 | 4,000 | $19K | 1.7% |
| 23 | $4.26 | 2,500 | $11K | 1.0% |
| 24 | $4.32 | 4,500 | $19K | 1.8% |
| 25 | $4.15 | 9,500 | $39K | 3.6% |
| 26 | $4.25 | 1,500 | $6K | 0.6% |
| 27 | $4.15 | 4,000 | $17K | 1.5% |
| 28 | $4.01 | 3,000 | $12K | 1.1% |
| 29 | $4.15 | 1,000 | $4K | 0.4% |
| 30 | $0.00 | 584,795 | $0 | 0.0% |
| Total | $1.27 avg | 869,103 | $1.1M | 100% |
| 2013-07-23 |
| $118K |
| — |
| Filing → |